Dean Investment Associates’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,368
Closed -$1.17M 219
2024
Q1
$1.17M Sell
3,368
-408
-11% -$155K 0.16% 184
2023
Q4
$1.73M Sell
3,776
-148
-4% -$72.9K 0.25% 165
2023
Q3
$1.91M Sell
3,924
-67
-2% -$31.5K 0.31% 125
2023
Q2
$1.78M Sell
3,991
-169
-4% -$85.1K 0.29% 123
2023
Q1
$2.02M Sell
4,160
-176
-4% -$87K 0.32% 111
2022
Q4
$2.22M Sell
4,336
-2
-0% -$1.05K 0.38% 97
2022
Q3
$2.1M Buy
4,338
+19
+0.4% +$9.24K 0.43% 93
2022
Q2
$2.02M Sell
4,319
-323
-7% -$144K 0.39% 98
2022
Q1
$2.02M Buy
4,642
+71
+2% +$29.7K 0.36% 105
2021
Q4
$2.12M Buy
+4,571
New +$2.02M 0.37% 101

Other funds holding HUM

Dean Investment Associates's HUM Position: Q2 2024 in Review

Dean Investment Associates sold out of Humana (HUM) in Q2 2024, closing a stake of 3,368 shares — an estimated $1.17M sold.

Dean Investment Associates first reported a position in HUM in Q4 2021 and held it in 10 quarters. The position peaked at $2.22M in Q4 2022. 979 funds tracked by Wall St. Rank hold HUM as of Q2 2024.

  • Dean Investment Associates reported no remaining Humana position as of Q2 2024 after selling out during the quarter.
  • Dean Investment Associates sold 3,368 Humana shares in Q2 2024, an estimated $1.17M.
  • Dean Investment Associates first reported a position in Humana in Q4 2021 and held it in 10 quarters.
  • Dean Investment Associates's Humana position peaked at $2.22M in Q4 2022.
  • 979 funds tracked by Wall St. Rank held Humana as of Q2 2024.

Based on Dean Investment Associates's 13F filing for Q2 2024, filed 13 Aug 2024.